C. Kaehler (Innsbruck, Austria), R. Morty (Giessen, Germany), D. Thickett (Birmingham, United Kingdom), M. Ochs (Hannover, Germany)
Nitrosative and cytokine status in patients with COPD and chronic cerebrovascular diseases (CCVD)
S. Soodaeva, T. Li, I. Klimanov, A. Lisitsa, N. Kubysheva, L. Postnikova, O. Mironova, A. Fedin (Moscow, Nizhny Novgorod, Russian Federation)
|  |
Leptin modulates host defense against chronic cigarette smoke inhalation in mice
J. H. J. Vernooy, I. M. J. Eurlings, G. F. J. Konings, J. Tavernier, G. F. Joos, G. G. Brusselle, E. F. M. Wouters, K. R. Bracke (Maastricht, Netherlands; Ghent, Belgium)
| |
Towards understanding the role of autoreactivity in COPD
T. Mes, T. Bijma, M. Nawijn, C. A. Brandsma, D. Bonarius, M. van Dijk, H. Kerstjens, W. Timens (Groningen, Netherlands)
| |
Paraoxonase activity in patients with COPD
T. Teke, E. Maden, A. Kiyici, T. T. Bekci, S. S. Erdem, M. Tosun, K. Uzun (Konya, Turkey)
| |
Model of staged development chronic obstructive pulmonary disease (COPD) in rats
I. Dvorakovskaya, E. Lebedeva, L. Danilov, N. Kuzubova (Saint-Petersburg, Russian Federation)
|  |
Lipoxin A4 receptor expression in smokers with and without COPD
L. Balode, S. Isajevs, D. Svirina, U. Kopeika, G. Strazda, I. Taivans (Riga, Latvia)
| |
Lung injury and apoptosis in COPD: Effect of a recombinant anti-protease derived from trappin-2
A. Tanga, A. Saidi, S. Dallet-Choisy, M. L. Zani, T. Moreau (Tours, France)
| |
Effect of phototherapy in phospholipids‘ composition of membranes of lymphocytes in experimental COPD
Y. Kayumova, Y. Tadjikhodjayeva, G. Sadikova (Tashkent, Uzbekistan)
| |
Possible role of 25-hydroxycholesterol on the pahogenesis of chronic obstructive pulmonary
H. Sugiura, A. Koarai, T. Ichikawa, M. Ichinose (Wakayama, Japan)
| |
Time course analysis of lung function and morphometric parameters in a murine model of emphysema
C. Olivo, B. Scarpa, F. Almeida, P. Arantes, F. Lopes, M. Martins (Sao Paulo, Brazil)
| |
Effects of cancer cachexia on the alveolar morphology of the mouse lung
T. Graulich, S. K. Das, G. Krasteva, L. Wessels, G. Höfler, C. Mühlfeld (Giessen, Germany; Graz, Austria)
| |
Aerobic training performed for short time do not decrease pulmonary allergic disease in mice
R. A. da Silva, R. de Paula Vieira, F. M. de Almeida, C. R. Olivo, B. M. Saraiva, M. A. Martins, C. R. F. de Carvalho (Sao Paulo, Brazil; Freiburg, Germany)
| |
Contribution of TGFβ1 and TIMP2 to clinical activity of asthma and COPD
N. Abolfath Zade Ghalejooghi, M. Ghanei, M. R. Nourani, A. Amini Harandi, A. A. Imani Fooladi (Tehran, Islamic Republic Of Iran)
| |
The role of cathepsin D, H & K in the regulation of tumstatin levels in asthmatic airways
J. Burgess, K. Grafton, G. Tjin, J. Middelburg, P. van Egmond, J. Black, B. Oliver (Sydney, Australia; Utrecht, Netherlands)
| |
Inhibitory profiles of alpha-1-antitrypsin from PiZ & PiSZ individuals and implications for tissue destruction in emphysema
N. Sinden, T. Dafforn, R. Stockley (Birmingham, United Kingdom)
| |
Acute effects of an aerobic exercise session on airway inflammation in a murine asthma model
R. A. da Silva, R. de Paula Vieira, F. M. de Almeida, C. R. Olivo, B. M. Saraiva, M. A. Martins, C. R. F. de Carvalho (Sao Paulo, Brazil; Freiburg, Germany)
| |
High doses of N-acetylcysteine alone or in combination with inhaled corticosteroids and oxidative stress in patients with COPD
V. Kapustina, S. Ovcharenko, P. Litvicki (Moscow, Russian Federation)
| |
Ceruloplasmine efficacy in patients with asthma exacerbations
U. Farkhutdinov, S. Farkhutdinov (Ufa, Russian Federation)
| |
Dynamics of oxidative stress parameters in exhaled breath condensate at controller treatment of bronchial asthma in patients with cold airway hyperpesponsiveness
J. M. Perelman, N. M. Goryachkina, A. G. Prikhodko, E. A. Borodin (Blagoveschensk, Russian Federation)
| |